First batch of EpiVacCorona-N vaccine released into public circulation
It is intended for clinical trials of the third phase, the Vector center, the vaccine’s developer, revealed
Source: tass.com
Stay updated with breaking news from Vector Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It is intended for clinical trials of the third phase, the Vector center, the vaccine’s developer, revealed
On December 6, the first two cases of infection with the omicron variant were recorded in Russia
The spread of the strain will not strongly impact the effectiveness of vaccines, Alexander Semyonov notes
According to Alexander Semyonov, different viral mutations affect various human organs in a different way
The official reported that over 100 mln sets of vaccines have entered civilian circulation